News

January 14, 2019January 14, 2019

Women with Crohn’s Disease Have Higher Risk of Mental Illness Post-pregnancy, Study Suggests

News

Women with Crohn’s disease are at a higher risk for mood disorders (depression and anxiety) and substance abuse issues after giving birth than those without inflammatory bowel disease (IBD), Canadian ... Read more

January 11, 2019January 11, 2019

Nominations Open for Sherman Prizes for Professional Achievement in IBD

News

Nominations are being accepted for the 2019 Sherman Prizes, which recognize trailblazing achievements in advancing patient care, medical research, public service and education in the fields of Crohn’s disease and ... Read more

January 9, 2019January 9, 2019

Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says

News

Worsening degrees of malnutrition are directly linked to a higher risk of 30-day complications in children with Crohn’s disease who have undergone major bowel surgery, a study says. The study, ... Read more

January 8, 2019January 8, 2019

Mind/Body Wellness as Way of Treating IBD: A Nutritionist’s View

News

In a previous column, I discussed diet and lifestyle choices that could help people with inflammatory bowel disease (IBD) move beyond just managing symptoms, so to reframe what it means ... Read more

January 7, 2019January 7, 2019

IBD May Raise Person’s Risk of Prostate Cancer, Study Reports

News

Men with a history of Crohn’s disease or ulcerative colitis may be more prone to prostate cancer than those without any inflammatory bowel disease, a review study suggests. The study “Inflammatory ... Read more

January 4, 2019January 4, 2019

Diet and Lifestyle Changes to Help Those with IBD ‘Take Back Control of Your Health’: A Nutritionist’s View

News

Inflammatory bowel disease (IBD) has been long touted as incurable, leaving people feeling disparate, depressed and hopeless. As a health professional who has been personally affected by irritable bowel and ... Read more

January 4, 2019January 4, 2019

Abivax to Present Results of Trials of ABX464 as Ulcerative Colitis Therapy

News

Abivax will present the complete results of its Phase 2a trial ABX464-101 (NCT03093259) and interim results of the open-label extension study ABX464-102 (NCT03368118). Both aimed to assess the safety and efficacy of ABX464 as a treatment ... Read more

January 2, 2019January 2, 2019

Immunic Will Develop IMU-856, Promising IBD Therapy

News

Immunic earned the exclusive rights to develop a group of innovative disease-modifying therapies, now renamed IMU-856, for inflammatory bowel disease (IBD). IMU-856, originally developed by Daiichi Sankyo, is an oral small ... Read more

December 19, 2018December 19, 2018

Protagonist Therapeutics Starts Phase 1 Trial of Potential Ulcerative Colitis Treatment PN-10943

News

Protagonist Therapeutics has begun dosing patients in a Phase 1 clinical trial of an oral ulcerative colitis (UC) treatment candidate known as PN-10943, the company announced in a press release. PN-10943 is ... Read more

December 14, 2018December 14, 2018

Janssen Launching Phase 1 Trial Testing VE202 for Potential IBD Treatment

News

Janssen Biotech will conduct a Phase 1 clinical trial in healthy volunteers to test VE202, an investigational oral treatment for inflammatory bowel disease (IBD), Vedanta Biosciences has announced. In 2015, Janssen bought ... Read more